Table 6.
SCR | Authors | Title | year of publication | Source title | Cited by |
---|---|---|---|---|---|
1st | Desjeux [43] | Leishmaniasis: Current situation and new perspectives | 2004 | Comparative Immunology, Microbiology and Infectious Diseases | 1971 |
2nd | Alvar et al. [39] | Leishmaniasis worldwide and global estimates of its incidence | 2012 | PLoS ONE | 1400 |
3rd | Belkaid et al. [40] | CD4 + CD25+ regulatory T cells control Leishmania major persistence and immunity | 2002 | Nature | 1277 |
4th | Herwaldt [44] | Leishmaniasis | 1999 | Lancet | 1204 |
5th | Murray et al. [6] | Advances in leishmaniasis | 2005 | Lancet | 1079 |
6th | Croft et al. [41] | Drug resistance in leishmaniasis | 2006 | Clinical Microbiology Reviews | 977 |
7th | Ivens et al. [45] | The genome of the kinetoplastid parasite, Leishmania major | 2005 | Science | 912 |
8th | Darrah et al. [42] | Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major | 2007 | Nature Medicine | 880 |
9th | Sacks et al. [46] | The immunology of susceptibility and resistance to Leishmania major in mice | 2002 | Nature Reviews Immunology | 764 |
10th | Chappuis et al. [47] | Visceral leishmaniasis: What are the needs for diagnosis, treatment and control? | 2007 | Nature Reviews Microbiology | 704 |
SCR Standard competition ranking